Spatial and single-cell transcriptomics landscape of adenomyosis

Yang X, Xing Yang, Li C, Chunjie Li, Junxian He, He J, Xie B, Bingbing Xie, Linyan Lv, Lv L, Jian Xu, Xu J, Yuan Lin, Lin Y, Zhou C, Chuanchuan Zhou, Li M, Manchao Li, Zhi Zeng, Zeng Z, Tan J, Jinfeng Tan, Chen S, Shuqin Chen, Cui G, Guizhong Cui, Guihua Liu, Liu G, Suo S, Shengbao Suo, Guangdun Peng, Peng G, Liang X, Xiaoyan Liang
Journal of advanced research · 2025 · doi:10.1016/j.jare.2025.12.042 · PMID:41456646 · W7117383359
article OA: gold CC0
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-11 ⓘ

This study used single-cell and spatial transcriptomics to identify ciliated epithelial cells and immune-inflammatory signatures in adenomyosis, finding that GnRHa treatment partially mitigates inflammation and restores epithelial-stromal interactions.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

INTRODUCTION: Adenomyosis is a prevalent gynaecological disorder affecting women of reproductive age, yet the underlying etiology and cellular-molecular mechanisms driving its pathogenesis remain poorly understood. Gonadotropin-releasing hormone agonists (GnRHa) are commonly used to improve clinical pregnancy rates in affected patients; however, their effects on specific cellular niches within the diseased uterus have not been fully elucidated. OBJECTIVE: This study aimed to profile adenomyosis at both the single-cell and spatial transcriptomic levels to examine various cell populations and systematically evaluate the effects of GnRHa treatment. METHODS: To characterize in depth the cellular and molecular landscape of adenomyosis, we employed single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics (Geo-seq) to profile 15 participants, including 11 patients with adenomyosis (three untreated and eight treated with GnRHa) and four control participants. For validation using immunofluorescence and immunohistochemistry, we included an additional two control subjects and 11 patients with adenomyosis. Furthermore, publicly available scRNA-seq datasets from samples collected during the proliferative phase of the menstrual cycle were incorporated for comparison. RESULTS: Our analysis revealed that ectopic endometrial glands in adenomyosis were enriched with ciliated epithelial cells, a feature that persisted following GnRHa treatment, suggesting a potential role of these cells in disease pathogenesis. Immune-inflammatory signatures, including elevated CD4+ T cells and LYVE1+ macrophages, were prominent in untreated adenomyosis, contributing to a pro-angiogenic microenvironment. This inflammatory and angiogenic activity was partially mitigated by GnRHa therapy. Notably, mast cells were found to be concentrated in the junctional zone, implicating this region as a potential site of disease initiation. CONCLUSION: Our findings provide evidence for the invagination theory, highlighting the involvement of ciliated epithelial cells and immune-angiogenic crosstalk in adenomyosis pathogenesis. Moreover, this study demonstrates that GnRHa exerts therapeutic effects through the normalization of immune cell composition and restoration of epithelial-stromal interaction, offering novel mechanistic insights into its mode of action.

My notes (saved in your browser only)

Condition tags

adenomyosis

Funding

funders
[{'doi': '10.13039/501100002402', 'name': 'Sun Yat-sen University', 'awards': ['R20210217202601970']}, {'doi': '10.13039/501100001809', 'name': 'National Natural Science Foundation of China', 'awards': ['82171604']}, {'doi': '10.13039/501100001809', 'name': 'National Natural Science Foundation of China', 'awards': ['32161160322']}, {'doi': '10.13039/501100001809', 'name': 'National Natural Science Foundation of China', 'awards': ['31871456']}, {'doi': '10.13039/501100001809', 'name': 'National Natural Science Foundation of China', 'awards': ['32000392']}, {'doi': '10.13039/501100001809', 'name': 'National Natural Science Foundation of China', 'awards': ['32270854']}, {'doi': '10.13039/501100001809', 'name': 'National Natural Science Foundation of China', 'awards': ['81971759']}, {'doi': '10.13039/501100001809', 'name': 'National Natural Science Foundation of China', 'awards': ['32370972']}, {'doi': '10.13039/501100021171', 'name': 'Basic and Applied Basic Research Foundation of Guangdong Province', 'awards': ['2023A1515011783']}, {'doi': '10.13039/501100021171', 'name': 'Basic and Applied Basic Research Foundation of Guangdong Province', 'awards': ['2023B1515020108']}, {'doi': '10.13039/501100021171', 'name': 'Basic and Applied Basic Research Foundation of Guangdong Province', 'awards': ['2019B151502054']}, {'doi': '10.13039/501100004000', 'name': 'Guangzhou Municipal Science and Technology Program key projects', 'awards': ['202206010089']}, {'doi': '10.13039/501100003453', 'name': 'Guangdong Provincial Natural Science Foundation', 'awards': ['2023A1515012940']}]

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (100)

Source provenance

crossref
last seen: 2026-05-16T01:00:27.959535+00:00
europepmc
last seen: 2026-07-28T06:14:09.330459+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-07-28T06:09:15.585742+00:00
License: CC0 · commercial use OK